Repetitive negative thinking is associated with amyloid, tau, and cognitive decline

Alzheimers Dement. 2020 Jul;16(7):1054-1064. doi: 10.1002/alz.12116. Epub 2020 Jun 7.

Abstract

Introduction: The Cognitive Debt hypothesis proposes that repetitive negative thinking (RNT), a modifiable process common to many psychological risk factors for Alzheimer's disease (AD) may itself increase risk. We sought to empirically examine relationships between RNT and markers of AD, compared with anxiety and depression symptoms.

Methods: Two hundred and ninety-two older adults with longitudinal cognitive assessments, including 113 with amyloid-positron emission tomography (PET) and tau-PET scans, from the PREVENT-AD cohort and 68 adults with amyloid-PET scans from the IMAP+ cohort were included. All participants completed RNT, anxiety, and depression questionnaires.

Results: RNT was associated with decline in global cognition (P = .02); immediate (P = .03) and delayed memory (P = .04); and global amyloid (PREVENT-AD: P = .01; IMAP+: P = .03) and entorhinal tau (P = .02) deposition. Relationships remained after adjusting for potential confounders.

Discussion: RNT was associated with decline in cognitive domains affected early in AD and with neuroimaging AD biomarkers. Future research could investigate whether modifying RNT reduces AD risk.

Keywords: Alzheimer's disease; amyloid; cognition; depression; repetitive negative thinking; rumination; tau; worry.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / psychology*
  • Amyloid beta-Peptides / metabolism*
  • Cognition / physiology*
  • Cognitive Dysfunction / diagnostic imaging
  • Cognitive Dysfunction / metabolism
  • Cognitive Dysfunction / psychology*
  • Female
  • Humans
  • Memory, Short-Term / physiology
  • Middle Aged
  • Neuropsychological Tests
  • Pessimism / psychology*
  • Positron-Emission Tomography
  • Risk Factors
  • Temporal Lobe / diagnostic imaging
  • Temporal Lobe / metabolism*
  • tau Proteins / metabolism*

Substances

  • Amyloid beta-Peptides
  • tau Proteins